Valeo Pharma Highlights MDBriefCase Newsletter Comparing Hesperidin
12 Jan 2021 //
PRNEWSWIRE
FDA has no objections to GRAS status of Spanish firm’s hesperidin
11 Mar 2019 //
NUTRAINGREDIENT
Anvisa Suspends Kern Pharma`s Perivasc Drug
17 Jun 2017 //
ANVISA
Body Plus Nutritional Products Inc Recalls of Precision Extreme Mega Test
19 Apr 2017 //
HEALTH CANADA
Oral hesperidin—Amorphization and improved dissolution properties
23 Nov 2016 //
PHARMA EXCIPIENTS